*We offer compounded versions of GLP-1 Weight Loss, which are not FDA-approved in any manner or clinically proven to provide any benefits
Its primary mechanism involves upregulating VEGF (vascular endothelial growth factor), which promotes new blood vessel growth at the site of damage
May 25, 2026$299/mo July 13, 2026$299/mo July 20, 2026$299/mo July 27, 2026$299/mo August 3, 2026$299/mo We check Knownwells published pricing every Monday
Sources: GLP-1 Agonists. The Cleveland Clinic.
Instead, the program may cover semaglutide (the generic equivalent) only if a patient has type 2 diabetes diagnosed first, or if they can demonstrate a documented medical comorbiditysuch as cardiovascular disease or severe sleep apneathat makes obesity a secondary treatment target rather than a primary one
Pillar 03 of the Longevity Code addresses the molecules the cell uses to sustain itself across time glutathione, NMN, NAD+ precursors, and the broader cellular architecture